Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling.

Huebner, Tatjana; Steffens, Michael; Scholl, Catharina

Huebner, Tatjana; Steffens, Michael; Scholl, Catharina.

Afiliação

Huebner T; Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, Bonn, 53175, Germany. Tatjana.Huebner@bfarm-research.de.
Steffens M; Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, Bonn, 53175, Germany.
Scholl C; Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, Bonn, 53175, Germany.

Mol Biol Rep ; 50(11): 9587-9599, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37787843

Assuntos

Sequenciamento de Nucleotídeos em Larga Escala; Farmacogenética; Farmacogenética/métodos; Sequenciamento de Nucleotídeos em Larga Escala/métodos; Sequenciamento Completo do Genoma; Citocromo P-450 CYP2D6; Exoma

Palavras-chave

Analytical validation; NGS; Next generation sequencing; PGx; Performance; Pharmacogenomics; Profiling; Third generation sequencing; WES; WGS; Whole exome sequencing; Whole genome sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google